col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


33 Results       Page 1

 [1] 
Springer (Biomed Central Ltd.): Cell & Bioscience
  original article Date Title Authors   All Authors
1 [GO] 2025―Apr―11 The influence of SARS-CoV-2 spike protein exposure on retinal development in the human retinal organoids Jing Gong, Lingling Ge, Yuxiao Zeng, Cao Yang, Yushan Luo, Jiahui Kang, et al. (+2)
2 [GO] 2024―Dec―20 The inactivation of the Niemann Pick C1 cholesterol transporter restricts SARS-CoV-2 entry into host cells by decreasing ACE2 abundance at the plasma membrane Piergiorgio La Rosa, Jessica Tiberi, Enrico Palermo, Roberta Stefanelli, Sofia Maria Luigia Tiano, Sonia Canterini, et al. (+3)
3 [GO] 2024―Sep―06 Targeting stress induction of GRP78 by cardiac glycoside oleandrin dually suppresses cancer and COVID-19 Dat P. Ha, Woo-Jin Shin, Ze Liu, Michael E. Doche, Roy Lau, Nektaria Maria Leli, et al. (+7)
4 [GO] 2024―Aug―02 SARS-CoV-2 variants divergently infect and damage cardiomyocytes in vitro and in vivo Bobo Wing-Yee Mok, Maxwell Kwok, Hung Sing Li, Lowell Ling, Angel Lai, Bin Yan, et al. (+20)
5 [GO] 2023―Nov―14 Coffee as a dietary strategy to prevent SARS-CoV-2 infection Chen-Shiou Wu, Yi-Chuan Li, Shin-Lei Peng, Chung-Yu Chen, Hsiao-Fan Chen, Po-Ren Hsueh, et al. (+6)
6 [GO] 2023―Aug―31 Engineered clinical-grade mesenchymal stromal cells combating SARS-CoV-2 omicron variants by secreting effective neutralizing antibodies Yanning Wang, Tianyun Gao, WanTing Li, Chenxu Tai, Yuanyuan Xie, Dong Chen, et al. (+5)
7 [GO] 2023―Jun―28 Umbelliferone and eriodictyol suppress the cellular entry of SARS-CoV-2 Fang-Ju Cheng, Chien-Yi Ho, Tzong-Shiun Li, Yeh Chen, Yi-Lun Yeh, Ya-Ling Wei, et al. (+11)
8 [GO] 2022―Oct―01 Revisiting potential value of antitumor drugs in the treatment of COVID-19 Wenfang Zheng, Zekun Zeng, Shumei Lin, Peng Hou
9 [GO] 2022―Jun―11 Development of a novel human CD147 knock-in NSG mouse model to test SARS-CoV-2 viral infection Saiaditya Badeti, Qingkui Jiang, Alireza Naghizadeh, Hsiang-chi Tseng, Yuri Bushkin, Salvatore A. E. Marras, et al. (+12)
10 [GO] 2022―May―19 Ginkgolic acid and anacardic acid are reversible inhibitors of SARS-CoV-2 3-chymotrypsin-like protease Dongsheng Li, Gangan Yan, Wenwen Zhou, Shuyi Si, Xiaoping Liu, Jing Zhang, et al. (+2)
11 [GO] 2022―May―17 Antibody engineering improves neutralization activity against K417 spike mutant SARS-CoV-2 variants Lili Li, Meiling Gao, Peng Jiao, Shulong Zu, Yong-qiang Deng, Dingyi Wan, et al. (+10)
12 [GO] 2022―Mar―22 SARS-CoV-2 NSP13 helicase suppresses interferon signaling by perturbing JAK1 phosphorylation of STAT1 Sin-Yee Fung, Kam-Leung Siu, Huayue Lin, Ching-Ping Chan, Man Lung Yeung, Dong-Yan Jin
13 [GO] 2022―Mar―20 Diabetes as a potential compounding factor in COVID-19-mediated male subfertility Qingkui Jiang, Thomas Linn, Karl Drlica, Lanbo Shi
14 [GO] 2022―Feb―09 Pseudomonas aeruginosa modulates alginate biosynthesis and type VI secretion system in two critically ill COVID-19 patients Jiuxin Qu, Zhao Cai, Xiangke Duan, Han Zhang, Hang Cheng, Shuhong Han, et al. (+8)
15 [GO] 2022―Feb―09 Transcriptional landscape of circulating platelets from patients with COVID-19 reveals key subnetworks and regulators underlying SARS-CoV-2 infection: implications for immunothrombosis Weiping Ji, Lu Chen, Wei Yang, Ke Li, Jingting Zhao, Congcong Yan, et al. (+4)
16 [GO] 2021―Dec―18 SARS-CoV-2 and COVID-19: revisiting the most important research questions Kit-San Yuen, Zi-Wei Ye, Sin-Yee Fung, Pak-Hin Hinson Cheung, Chi-Ping Chan, Dong-Yan Jin
17 [GO] 2021―Dec―08 Intranasal HD-Ad vaccine protects the upper and lower respiratory tracts of hACE2 mice against SARS-CoV-2 Huibi Cao, Juntao Mai, Zhichang Zhou, Zhijie Li, Rongqi Duan, Jacqueline Watt, et al. (+14)
18 [GO] 2021―Dec―05 Development of a simple and miniaturized sandwich-like fluorescence polarization assay for rapid screening of SARS-CoV-2 main protease inhibitors Gangan Yan, Dongsheng Li, Yuan Lin, Zhenghao Fu, Haiyan Qi, Xiaoping Liu, et al. (+3)
19 [GO] 2021―Nov―21 Impaired neutralizing antibody response to COVID-19 mRNA vaccines in cancer patients Cong Zeng, John P. Evans, Sarah Reisinger, Jennifer Woyach, Christina Liscynesky, Zeinab El Boghdadly, et al. (+8)
20 [GO] 2021―Sep―08 Inferring SARS-CoV-2 functional genomics from viral transcriptome with identification of potential antiviral drugs and therapeutic targets Xu Pan, Xin Li, Shangwei Ning, Hui Zhi
21 [GO] 2021―Aug―30 Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor Jinbiao Liu, Brittany H. Bodnar, Fengzhen Meng, Adil I. Khan, Xu Wang, Sami Saribas, et al. (+11)
22 [GO] 2021―Aug―22 An update on novel approaches for diagnosis and treatment of SARS-CoV-2 infection Azadeh Safarchi, Shadma Fatima, Zahra Ayati, Fatemeh Vafaee
23 [GO] 2021―Jul―22 Genome-wide analysis of protein-protein interactions and involvement of viral proteins in SARS-CoV-2 replication Yiling Jiang, Kuijie Tong, Roubin Yao, Yuanze Zhou, Hanwen Lin, Liubing Du, et al. (+7)
24 [GO] 2021―Jul―19 Differing susceptibility of C57BL/6J and DBA/2J mice-parents of the murine BXD family, to severe acute respiratory syndrome coronavirus infection Kui Li, Yang Shen, Mark A. Miller, Jennifer Stabenow, Robert W. Williams, Lu Lu
25 [GO] 2021―Jul―19 SARS-CoV-2: from its discovery to genome structure, transcription, and replication Ayslan Castro Brant, Wei Tian, Vladimir Majerciak, Wei Yang, Zhi-Ming Zheng
26 [GO] 2021―Jul―08 A bivalent protein targeting glycans and HR1 domain in spike protein potently inhibited infection of SARS-CoV-2 and other human coronaviruses Yanxing Cai, Wei Xu, Jiayi Tang, Najing Cao, Qiaoshuai Lan, Lu Lu, Shibo Jiang
27 [GO] 2021―Jun―23 Deletion of ER-retention motif on SARS-CoV-2 spike protein reduces cell hybrid during cell-cell fusion Xuening Wang, Chih-Hsiung Chen, Saiaditya Badeti, Jong Hyun Cho, Alireza Naghizadeh, Ziren Wang, Dongfang Liu
28 [GO] 2021―Jun―13 Drosophila, a powerful model to study virus-host interactions and pathogenicity in the fight against SARS-CoV-2 Joyce van de Leemput, Zhe Han
29 [GO] 2021―Mar―25 Functional analysis of SARS-CoV-2 proteins in Drosophila identifies Orf6-induced pathogenic effects with Selinexor as an effective treatment Jun-yi Zhu, Jin-Gu Lee, Joyce van de Leemput, Hangnoh Lee, Zhe Han
30 [GO] 2021―Mar―25 Characterization of SARS-CoV-2 proteins reveals Orf6 pathogenicity, subcellular localization, host interactions and attenuation by Selinexor Jin-Gu Lee, Weiliang Huang, Hangnoh Lee, Joyce van de Leemput, Maureen A. Kane, Zhe Han
31 [GO] 2021―Feb―28 Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteases Zinuo Chen, Qinghua Cui, Laura Cooper, Pin Zhang, Hyun Lee, Zhaoyu Chen, et al. (+4)
32 [GO] 2020―Dec―30 ACE2: the molecular doorway to SARS-CoV-2 Miriam Marlene Medina-Enríquez, Sandra Lopez-León, José Alberto Carlos-Escalante, Zuleika Aponte-Torres, Angelica Cuapio, Talia Wegman-Ostrosky
33 [GO] 2020―Mar―16 SARS-CoV-2 and COVID-19: The most important research questions Kit-San Yuen, Zi -Wei Ye, Sin-Yee Fung, Chi-Ping Chan, Dong-Yan Jin
 [1] 

33 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.003 sec